NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 243 filers reported holding NEOGENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82 | -24.8% | 6,683 | -1.5% | 0.00% | -25.0% |
| Q2 2023 | $109 | -8.4% | 6,786 | -0.6% | 0.00% | -20.0% |
| Q1 2023 | $119 | +88.9% | 6,827 | -0.3% | 0.01% | +66.7% |
| Q4 2022 | $63 | -99.9% | 6,850 | -7.2% | 0.00% | +50.0% |
| Q3 2022 | $64,000 | -5.9% | 7,381 | -11.4% | 0.00% | 0.0% |
| Q2 2022 | $68,000 | -32.0% | 8,329 | +1.3% | 0.00% | 0.0% |
| Q1 2022 | $100,000 | -68.9% | 8,220 | -13.0% | 0.00% | -71.4% |
| Q4 2021 | $322,000 | +81.9% | 9,450 | +157.9% | 0.01% | +75.0% |
| Q3 2021 | $177,000 | +2.3% | 3,664 | -4.4% | 0.00% | +33.3% |
| Q2 2021 | $173,000 | -6.5% | 3,834 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $185,000 | – | 3,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |